Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Kidswell Bio Corporation banner
K

Kidswell Bio Corporation
TSE:4584

Watchlist Manager
Kidswell Bio Corporation
TSE:4584
Watchlist
Price: 260 JPY -2.99%
Market Cap: ¥12.9B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Kidswell Bio Corporation

Wall Street analysts forecast Kidswell Bio Corporation stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Kidswell Bio Corporation is 459 JPY with a low forecast of 454.5 JPY and a high forecast of 472.5 JPY.

Lowest Forecast
Wall Street Target
454.5 JPY
75% Upside
Average Forecast
Wall Street Target
459 JPY
77% Upside
Highest Forecast
Wall Street Target
472.5 JPY
82% Upside
Lowest
Price Target
454.5 JPY
75% Upside
Average
Price Target
459 JPY
77% Upside
Highest
Price Target
472.5 JPY
82% Upside
Kidswell Bio Corporation Competitors:
Price Targets
ESQ
Esquire Financial Holdings Inc
16% Upside
CSGP
CoStar Group Inc
68% Upside
LAND
Gladstone Land Corp
2% Upside
TCPC
BlackRock TCP Capital Corp
41% Upside
ESQ
Esquire Financial Holdings Inc
16% Upside
CSGP
CoStar Group Inc
68% Upside
LAND
Gladstone Land Corp
2% Upside
TCPC
BlackRock TCP Capital Corp
41% Upside

Revenue
Forecast

28% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
28% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

For the last 13 years the compound annual growth rate for Kidswell Bio Corporation's revenue is 28%. The projected CAGR for the next 2 years is -1%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Kidswell Bio Corporation

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss

What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Kidswell Bio Corporation's stock price target?
Price Target
459 JPY

According to Wall Street analysts, the average 1-year price target for Kidswell Bio Corporation is 459 JPY with a low forecast of 454.5 JPY and a high forecast of 472.5 JPY.

What is Kidswell Bio Corporation's Revenue forecast?
Projected CAGR
-1%

For the last 13 years the compound annual growth rate for Kidswell Bio Corporation's revenue is 28%. The projected CAGR for the next 2 years is -1%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.